AAAAAA

   
Results: 1-17 |
Results: 17

Authors: CHUDZINSKITAVASSI AM KELEN EMA DEPAULAROSA AP LOYAU S SAMPAIO CAM BON C ANGLESCANO E
Citation: Am. Chudzinskitavassi et al., FIBRINO(GENO)LYTIC PROPERTIES OF PURIFIED HEMENTERIN, A METALLOPROTEINASE FROM THE LEECH HAEMENTERIA-DEPRESSA, Thrombosis and haemostasis, 80(1), 1998, pp. 155-160

Authors: SOULAT T LOYAU S SCHLEGEL N LOIRAT C ANGLESCANO E
Citation: T. Soulat et al., LOW PLASMINOGEN AND HIGH LIPOPROTEIN(A) LEVELS IN CHILDREN WITH THE NEPHROTIC SYNDROME - POSSIBLE RELATION TO THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 1329-1329

Authors: DELAPENA A LOYAU S IZAGUIRRE R ANGLESCANO E
Citation: A. Delapena et al., FUNCTIONAL IDENTIFICATION OF LIPOPROTEIN LP(A) IN PLASMA FROM PATIENTS WITH CARDIOVASCULAR-DISEASE, Thrombosis and haemostasis, 1997, pp. 1330-1330

Authors: SOULAT T LOYAU S LOIRAT C ANGLESCANO E
Citation: T. Soulat et al., THE FIBRINOLYTIC-ACTIVITY OF PLASMA DEPENDS ON THE CONCENTRATIONS OF PLASMINOGEN AND LIPOPROTEIN LP(A) AND ON THEIR INTERPLAY WITH FIBRIN, Thrombosis and haemostasis, 1997, pp. 1332-1332

Authors: ANGLESCANO E LOYAU S KANG C COUDERC R VALENTI K MULLER JH
Citation: E. Anglescano et al., A NOVEL KRINGLE-4 NUMBER-BASED RECOMBINANT APO(A) STANDARD FOR HUMAN LP(A) PHENOTYPING, Thrombosis and haemostasis, 1997, pp. 2290-2290

Authors: LOYAU S IACOVIELLO L DONATI MB ANGLESCANO E
Citation: S. Loyau et al., AN INNOVATIVE IMMUNORADIOMETRIC ASSAY-METHOD FOR THE DETECTION OF PATHOGENIC LP(A) ISOFORMS, Thrombosis and haemostasis, 1997, pp. 2298-2298

Authors: ANGLESCANO E LOYAU S KANG C COUDERC R VALENTI K MULLER JH
Citation: E. Anglescano et al., A NOVEL KRINGLE-4 NUMBER-BASED RECOMBINANT APO(A) STANDARD FOR HUMAN LP(A) PHENOTYPING, Atherosclerosis, 134(1-2), 1997, pp. 137-137

Authors: KANG C LOYAU S SOULAT T MULLER HJ ANGLESCANO E
Citation: C. Kang et al., IDENTIFICATION OF KRINGLES OF APOLIPOPROTEIN(A) THAT ENABLE ITS BINDING TO FIBRIN AND MONOCYTIC CELLS, Atherosclerosis, 134(1-2), 1997, pp. 141-141

Authors: LOYAU S DELAPENA L IACOVIELLO L IZAGUIRRE R DONATI MB ANGLESCANO E
Citation: S. Loyau et al., FIBRIN-BINDING METHOD FOR THE FUNCTIONAL IDENTIFICATION OF LIPOPROTEIN(A) IN PLASMA FROM PATIENTS WITH CARDIOVASCULAR-DISEASE, Atherosclerosis, 134(1-2), 1997, pp. 144-144

Authors: SALAZARPARAMO M DELATORRE IG FRITZLER MJ LOYAU S ANGLESCANO E
Citation: M. Salazarparamo et al., ANTIBODIES TO FIBRIN-BOUND TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARE ASSOCIATED WITH RAYNAUDS-PHENOMENON AND THROMBOSIS, Lupus, 5(4), 1996, pp. 275-278

Authors: FRITZLER MJ HART DA WILSON D TORRE IGD SALAZARPARAMO M VAZQUEZDELMERCADO M SENECAL JL LOYAU S ANGLESCANO E
Citation: Mj. Fritzler et al., ANTIBODIES TO FIBRIN BOUND TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN SYSTEMIC-SCLEROSIS, Journal of rheumatology, 22(9), 1995, pp. 1688-1693

Authors: ANGLESCANO E GRIS JC LOYAU S SCHVED JF
Citation: E. Anglescano et al., PLASMINOGEN ACTIVATION IN PLASMAS FROM A FAMILY WITH HIGH-LEVELS OF HISTIDINE-RICH GLYCOPROTEIN (HRGP) - IS HRGP A CONTRIBUTING FACTOR TO THROMBOSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 1092-1092

Authors: ANGLESCANO E RUIZARGUELLES A PEREZROMANO B LOYAU S ARGUELLES GJR DELEZE M ALARCONSEGOVIA D
Citation: E. Anglescano et al., AUTOANTIBODIES DIRECTED AGAINST DIFFERENT MOLECULAR CONFIGURATIONS OFTISSUE-TYPE PLASMINOGEN-ACTIVATOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS, Thrombosis and haemostasis, 69(6), 1993, pp. 1095-1095

Authors: ANGLESCANO E HERVIO L LOYAU S
Citation: E. Anglescano et al., RELEVANCE OF LIPOPROTEIN(A) IN CARDIOVASCULAR-DISEASE - METHODOLOGICAL APPROACHES, Fibrinolysis, 7, 1993, pp. 66-68

Authors: ANGLESCANO E GRIS JC LOYAU S SCHVED JF
Citation: E. Anglescano et al., FAMILIAL ASSOCIATION OF HIGH-LEVELS OF HISTIDINE-RICH GLYCOPROTEIN AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 WITH VENOUS THROMBOEMBOLISM, The Journal of laboratory and clinical medicine, 121(5), 1993, pp. 646-653

Authors: FLEURY V LOYAU S LIJNEN HR NIEUWENHUIZEN W ANGLESCANO E
Citation: V. Fleury et al., MOLECULAR ASSEMBLY OF PLASMINOGEN AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR ON AN EVOLVING FIBRIN SURFACE, European journal of biochemistry, 216(2), 1993, pp. 549-556

Authors: HERVIO L CHAPMAN MJ THILLET J LOYAU S ANGLESCANO E
Citation: L. Hervio et al., DOES APOLIPOPROTEIN(A) HETEROGENEITY INFLUENCE LIPOPROTEIN(A) EFFECTSON FIBRINOLYSIS, Blood, 82(2), 1993, pp. 392-397
Risultati: 1-17 |